Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Agenus Inc.
DescriptionHuman antibody targeting gB protein of human Cytomegalovirus (hCMV)
Molecular Target Human cytomegalovirus (CMV) glycoprotein B
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationCytomegalovirus (CMV)
Indication DetailsTreat CMV infections in patients with bone marrow and hematopoietic stem cell transplant
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today